ClinicalTrials.gg
CompletedNCT07724483PODUSGUpdated Oct 7, 2026

Ultrasonographic Evaluation and Pedobarographic Correlation of Lower Extremity Muscles in Lipedema Patients

An observational study in Lipedema and Obesity & Overweight, sponsored by Marmara University. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-07.

Sponsored by Marmara University · Observational

Updated Oct 7, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓
Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
100
Ages
18 Years to 65 Years
Sex
Female
01

Study summary

The primary aim of this study is to evaluate the lower extremity muscle structure, lower extremity alignment, and foot posture in lipedema; secondly, to reveal the chain relationship and biomechanical problems that may be observed in lipedema patients. Lipedema is a condition characterized by abnormal fat accumulation that can lead to walking difficulties and joint problems. We will use ultrasonography to measure muscle thickness and tendon structures, and a pedobarography system to analyze foot pressure distribution during standing and walking. By comparing 50 women diagnosed lipedema with 50 healthy volunteers, we aim to identify the musculoskeletal causes of gait disorders in lipedema to help develop better prevention and treatment strategies

Read the detailed description

Lipedema is a disease affecting fat tissues. Fat accumulates abnormally, especially in the hips and lower extremities. It was first described by Worl et al. The cause of the disease is unknown at the current level of scientific knowledge. Lipedema usually occurs in women during adolescence and the third decade. Although there is usually no lymphatic flow dysfunction in these patients, they are often misdiagnosed with lymphedema, but lipedema can cause secondary lymphatic dysfunction, leading to the development of lipolymphedema.

Lipedema is a clinical diagnosis. It is evaluated with appropriate history taking and physical examination. It can be detected by symptoms such as easy bruising, difficulty in losing weight from the legs while losing weight from the trunk, the presence of women with similar conditions in the family, pain on pressure, disproportion between the upper and lower body, pearl-sized nodules on the thighs, and decreased tissue and fascia elasticity on physical examination.

Ultrasonography (USG) muscle thickness measurement is a reliable method for determining regional muscle mass. Previous studies in the literature have evaluated the rectus femoris, gastrocnemius, gluteus medius and posterior tibialis muscles with USG and appropriate measurement techniques have been determined in these studies.

Pedobarography is a technology that evaluates a person's gait, balance, and consequently their locomotor system by examining the pressure distributions on the sole of the foot. It can be used diagnostically in the evaluation of lower extremity pathologies. Pedobarographic examination can provide static, postural, and dynamic evaluation. Static evaluation assesses the plantar pressure distribution during a certain standing time, while postural evaluation examines the pressure distributions in different standing positions. Dynamic evaluation assesses the load distribution on the sole of the foot during walking.

It is known that foot mechanics are affected in patients with lipedema. Considering that the load on the foot is increased in this patient group and that the majority of this load is caused by atypically stored fat, impairment of foot function is inevitable, especially in advanced stages. This is attributed to the valgus position of the knee and the disruption of the medial arch of the foot due to weakness of the knee extensors and hip abductors, and it has also been stated that these alignment problems may be due to gait disorders. Furthermore, it is known that obesity, which may occur simultaneously with lipedema, can lead to additional problems in mobility, and this limited mobility also increases the risk of depression. In addition, predominant sarcopenia in the thigh can be observed in these patients. In this case, weakness of the gluteus medius and quadriceps femoris that may develop contributes to the development of dynamic valgus in the knee. With the development of dynamic valgus, patellar displacement may occur, and as a result, chondromalacia may develop.

Considering the walking problems frequently observed in lipedema patients, it is crucial to address the root causes of these problems, preventing them where possible and detecting them when intervention is required. To achieve this, an assessment of potential problems and identification of related muscle and tendon dysfunctions are necessary to determine their causes. The aim of this study is to evaluate musculoskeletal problems in the lower extremities of lipedema patients, particularly those related to gait and posture, and their functional implications, and to determine the relationship between these functional problems and measurements of muscles and tendons using ultrasonography.

Study Methodology:

Design: Cross-sectional case-control study. Participants: 45 female patients with lipedema and 45 healthy controls. Clinical Evaluation: BMI, waist-hip ratio, leg volume calculation, and Foot Posture Index-6.

Functional Assessment: 6-Minute Walk Test. Questionnaires: Rapprich Lipedema Symptomatic Assessment, LYMPQOL-LEG and Short Form-36 USG Protocol: Measurement of M. Rectus Femoris, Gastrocnemius, Tibialis Posterior, and Gluteus Medius thickness using Esaote MyLab Seven lineer probe [SL1543].

Pedobarography: Static and dynamic 6-phase gait analysis using ACK Medical pedogram system.

Statistical Analysis: Group comparisons and Pearson/Spearman correlation analysis will be performed using SPSS.

02

Conditions studied

  • Lipedema
  • Obesity & Overweight

Keywords

  • Lipedema
  • Pedobarography
  • Musculoskeletal Ultrasound
  • Rectus Femoris
  • Gastrocnemius
  • Posterior Tibialis
  • Gluteus Medius
  • Achilles
  • STAR
03

In context

Lipedema

85 studies on the registry are indexed under Lipedema; 32 are open to participants now.

This study's enrollment of 100 is above the median of 90 across 42 observational studies indexed under Lipedema.

Browse Lipedema studies →

Lead sponsor

Marmara University is the lead sponsor of 599 studies on the registry; 138 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Female patients aged 18-65 years diagnosed with lipedema by a clinician and their age- and BMI-matched healthy volunteers

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female patients aged 18-65 years and diagnosed with lipedema by a clinician.
  • To agree to participate in the research.

Exclusion criteria

Exclusion Criteria:

  • Positivity of Stemmer's sign (inability to compress the skin between the proximal phalanges of the 2nd and 3rd fingers)
  • Patients with Heart Failure
  • Patients with Chronic Kidney Disease
  • Motor neuron diseases or myositis
  • Diseases causing myositis
  • Patients diagnosed with polyneuropathy
  • Patients with motor-involved L3, L4, L5, or S1 radiculopathy
  • Those unable to ambulate independently
  • Those who cannot tolerate the assessments
  • Pregnant women
  • Congenital or traumatic lower extremity disorders (e.g., developmental hip dysplasia, previous lower extremity fractures with orthopaedic implants).
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
100 participants (actual)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Lipedema

    Patients Diagnosed Lipedema

  • Healthy Volunteer

    Healthy Volunteers thoose age- and BMI-matched

06

What researchers measure

Primary outcomes

  1. M. Rectus Femoris Muscle Thickness

    Measurement of thickness (mm) for M. Rectus Femoris with B-mode Ultrasonography (Esaote MyLab Seven). With the participant's knee fully extended and in a supine position, the transverse section of the image obtained from the midpoint of the distance between the SIAS and the upper edge of the patella was used to measure the RF thickness, excluding the fascial boundaries.

    Time frame: At baseline (Day 0)

  2. M. Gastrocnemius Medialis Muscle Thickness

    Measurement of thickness (mm) for Gastrocnemius Medialis via B-mode Ultrasonography (Esaote MyLab Seven). With the participant in the prone position, muscle thickness (distance between superficial and deep fascia) was measured in a longitudinal section at the proximal 1/3 of the muscle, where it is widest.

    Time frame: At baseline (Day 0)

  3. M. Tibialis Posterior Muscle Thickness

    Measurement of thickness (mm) for M. Tibialis Posterior via B-mode Ultrasonography (Esaote MyLab Seven). With the participant in the supine position, the muscle running deep within the tibialis anterior, at approximately 30% of the lateral malleolus and between the lateral knee joint space, was identified. The thickness of the muscle was assessed at the midline in the transverse section.

    Time frame: At Baseline (Day 0)

  4. M. Gluteus Medius Muscle Thickness

    Measurement of thickness (mm) for M. Gluteus Medius via B-mode Ultrasonography (Esaote MyLab Seven). The participant was positioned in the LD position, with both legs crossed and hips and knees flexed at 30°. The midpoint between the major trochanter and the crista iliaca was located and measured longitudinally. The thickness of the muscle located in the deep compartment was evaluated in the longitudinal section.

    Time frame: At Baseline (Day 0)

  5. Clarke's Angle

    Measurement of Clarke's angle (in degrees) derived from the plantar pressure distribution to objectively evaluate the integrity of the medial longitudinal arch.

    Time frame: At baseline (Day 0).

  6. Foot Posture Index-6 (FPI-6) Score

    Assessment of foot posture (pronation, supination, or neutral) based on six clinical criteria, providing a total score for foot alignment

    Time frame: At baseline (Day 0)

  7. Genu Valgum

    In genu valgum examination, the intermalleolar distance was measured while the participant had both knees together, and values greater than 8 cm were considered positive. In participants with an increase in intermalleolar distance, the tibiofemoral angle was measured, and values above 5° were considered genu valgum.

    Time frame: At baseline (Day 0)

  8. Genu Recurvatum

    In the genu recurvatum assessment, participants were placed in a supine position with a cushion under their heels, the goniometer was placed on the lateral femoral condyle, the tips of the goniometer were aligned with the greater trochanter and the lateral malleolus, and goniometric knee hyperextension was measured; values above 5° were considered positive.

    Time frame: At Baseline (Day 0)

Secondary outcomes

  1. Static Pedobarographic Weight Distribution Left& Right

    Evaluation of the percentage (%) of weight distribution between left and right feet during static standing.

    Time frame: At baseline (Day 0)

  2. Static Pedobarographic Weight Distribution Forefoot& Hindfoot

    Evaluation of the percentage (%) of weight distribution between forefoot and hindfoot pressure ratio during static standing.

    Time frame: At Baseline (Day 0)

  3. Center of Pressure (COP) Sway Area

    Measurement of the area (mm\^2) covered by the center of pressure during static standing to assess postural stability.

    Time frame: At baseline (Day 0)

  4. Center of Pressure (COP) Sway Velocity

    Measurement of the movement speed (mm/s) of the center of pressure during static standing.

    Time frame: At baseline (Day 0)

  5. Dynamic Peak Plantar Pressures

    Measurement of maximum peak pressure (N/cm\^2) during 6 gait phases (Heel Strike, Foot Flat, Mid-stance, Heel Off, Toe Off) using the pedogram system.

    Time frame: At baseline (Day 0)

  6. Patellar Tendon Cross-Sectional Area (CSA)

    Measurement of cross-sectional area (mm\^2) for Patellar tendon using B-mode Ultrasonography (Esaote MyLab Seven). For the patellar tendon, a cross-sectional area (CSA, mm²) was drawn in a transverse section between the lower end of the patella and the midpoint of the tibial tuberosity with the knee flexed at 30°; the tendon thickness was measured in millimeters in a longitudinal section.

    Time frame: At baseline (Day 0)

  7. Achilles Tendon Cross-Sectional Area (CSA)

    Measurement of cross-sectional area (mm\^2) for Achilles tendon using B-mode Ultrasonography (Esaote MyLab Seven). With the ankle in a 90° neutral position, and the participant in the prone position, CSA (mm²) measurement was performed in a transverse section with the probe positioned at a perfect right angle to the tendon at the level of the medial malleolus, with a dense gel layer underneath.

    Time frame: At Baseline (Day 0)

  8. Tibialis Posterior Tendon Cross-Sectional Area (CSA)

    Measurement of cross-sectional area (mm\^2) for tibialis posterior tendon using B-mode Ultrasonography (Esaote MyLab Seven). For the tendon, the participant was positioned in the lateral decubitus position, with the side to be evaluated close to the operator and medial to the anterior aspect. Images were acquired through the retromalleolar canal immediately behind the Medial Malleolus. A transverse section was obtained and measured at the point where the tendon wraps around the MM.

    Time frame: At Baseline (Day 0)

Other outcomes

  1. Rapprich Lipedema Symptomatic Assessment Score

    A 15-item scale (0-10 points each) assessing the severity of symptoms such as pain, tension, sensitivity, and easy bruising in the legs. Total score ranges from 0 to 150

    Time frame: At baseline (Day 0)

  2. LYMPQOL-LEG (Lymphedema Quality of Life Questionnaire - Leg)

    A questionnaire evaluating the impact of the condition on daily activities, symptoms, social life, and clothing choices

    Time frame: At baseline (Day 0)

  3. 6-Minute Walk Test (6MWT) Distance

    Evaluation of functional exercise capacity measured in meters. The test was administered in a 30-meter straight corridor, following standard verbal instructions, in accordance with the American Thoracic Society guidelines.

    Time frame: At baseline (Day 0)

  4. Subcutaneous Fat Tissue Thickness

    Measurement of subcutaneous fat thickness (mm) at standardized regions (anterior thigh, medial thigh, lateral calf, arm, and forearm) via Ultrasonography (Esaote MyLab Seven).

    Time frame: At baseline (Day 0)

  5. Waist to Hip Ratio

    Waist circumference was measured at the midpoint between the lower edge of the costal margin and the iliac crest; hip circumference was measured at the widest point of the gluteal region, with the participant standing and at the end of normal expiration, using a non-stretching measuring tape according to the World Health Organization protocol.

    Time frame: At Baselin (Day 0)

07

Study locations

1 site
  • Marmara University School of Medicine Pendik Research and Training Hospital
    Istanbul, Pendik 34899, Turkey (Türkiye)
08

References and documents

Publications

  • Rapprich S, Dingler A, Podda M. Liposuction is an effective treatment for lipedema-results of a study with 25 patients. J Dtsch Dermatol Ges. 2011 Jan;9(1):33-40. doi: 10.1111/j.1610-0387.2010.07504.x. Epub 2010 Sep 7. English, German. PubMed 21166777 ↗
  • Yalfani A, Ahmadi M, Asgarpoor A. The effect of kinetic factors of dynamic knee valgus on patellofemoral pain: A systematic review and meta-analysis. J Bodyw Mov Ther. 2024 Jan;37:246-253. doi: 10.1016/j.jbmt.2023.11.001. Epub 2023 Nov 14. PubMed 38432813 ↗
  • Linsmayer D, Neidlinger PK, Braus DF. [Rheumatism and the mind-A mini review]. Orthopade. 2019 Nov;48(11):957-962. doi: 10.1007/s00132-019-03812-8. German. PubMed 31559467 ↗
  • Volkan-Yazici M, Yazici G, Esmer M. The Effects of Complex Decongestive Physiotherapy Applications on Lower Extremity Circumference and Volume in Patients with Lipedema. Lymphat Res Biol. 2021 Feb;19(1):111-114. doi: 10.1089/lrb.2020.0080. Epub 2020 Oct 30. PubMed 33124947 ↗
  • Amato AC. Chondromalacia in Lipedema: The Sarcopenic-Valgus Cascade That Keeps Getting Missed. Cureus. 2025 Oct 24;17(10):e95299. doi: 10.7759/cureus.95299. eCollection 2025 Oct. PubMed 41287673 ↗
  • Faerber G, Cornely M, Daubert C, Erbacher G, Fink J, Hirsch T, Mendoza E, Miller A, Rabe E, Rapprich S, Reich-Schupke S, Stucker M, Brenner E. S2k guideline lipedema. J Dtsch Dermatol Ges. 2024 Sep;22(9):1303-1315. doi: 10.1111/ddg.15513. Epub 2024 Aug 27. PubMed 39188170 ↗
  • Buso G, Depairon M, Tomson D, Raffoul W, Vettor R, Mazzolai L. Lipedema: A Call to Action! Obesity (Silver Spring). 2019 Oct;27(10):1567-1576. doi: 10.1002/oby.22597. PubMed 31544340 ↗
  • Guven M, Kocadal O, Akman B, Poyanli OS, Kemah B, Atay EF. Proximal femoral nail shows better concordance of gait analysis between operated and uninjured limbs compared to hemiarthroplasty in intertrochanteric femoral fractures. Injury. 2016 Jun;47(6):1325-31. doi: 10.1016/j.injury.2016.03.009. Epub 2016 Mar 12. PubMed 27017452 ↗
  • Lorkowski J, Zarzycki D. [Clinical use of pedobarographic examination--own experience and review of literature]. Przegl Lek. 2006;63 Suppl 5:28-32. Polish. PubMed 17469520 ↗
  • Lorkowski J, Gawronska K. Pedobarography in Physiotherapy: A Narrative Review on Current Knowledge. Adv Exp Med Biol. 2022;1375:13-22. doi: 10.1007/5584_2021_636. PubMed 33914289 ↗
  • Neville C, Meyers K, Hojnowski L. Ultrasound assessment of the tibialis posterior tendon. J Orthop Sports Phys Ther. 2010 Oct;40(10):667. doi: 10.2519/jospt.2010.0417. No abstract available. PubMed 20885025 ↗
  • Johnson AW, Bruening DA, Violette VA, Perkins KV, Thompson CL, Ridge ST. Ultrasound Imaging Is Reliable for Tibialis Posterior Size Measurements. J Ultrasound Med. 2020 Dec;39(12):2305-2312. doi: 10.1002/jum.15340. Epub 2020 May 15. PubMed 32412115 ↗
  • Whittaker JL, Emery CA. Sonographic measures of the gluteus medius, gluteus minimus, and vastus medialis muscles. J Orthop Sports Phys Ther. 2014 Aug;44(8):627-32. doi: 10.2519/jospt.2014.5315. Epub 2014 Jul 16. PubMed 25029916 ↗
  • Sheptulina AF, Yafarova AA, Mamutova EM, Drapkina OM. Sonographic Features of Rectus Femoris Muscle in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease and Their Correlation with Body Composition Parameters and Muscle Strength: Results of a Single-Center Cross-Sectional Study. Biomedicines. 2024 Jul 28;12(8):1684. doi: 10.3390/biomedicines12081684. PubMed 39200149 ↗
  • Kara M, Kaymak B, Ata AM, Ozkal O, Kara O, Baki A, Sengul Aycicek G, Topuz S, Karahan S, Soylu AR, Cakir B, Halil M, Ozcakar L. STAR-Sonographic Thigh Adjustment Ratio: A Golden Formula for the Diagnosis of Sarcopenia. Am J Phys Med Rehabil. 2020 Oct;99(10):902-908. doi: 10.1097/PHM.0000000000001439. PubMed 32941253 ↗
  • Nijholt W, Scafoglieri A, Jager-Wittenaar H, Hobbelen JSM, van der Schans CP. The reliability and validity of ultrasound to quantify muscles in older adults: a systematic review. J Cachexia Sarcopenia Muscle. 2017 Oct;8(5):702-712. doi: 10.1002/jcsm.12210. Epub 2017 Jul 12. PubMed 28703496 ↗
  • van la Parra RFD, Deconinck C, Pirson G, Servaes M, Fosseprez P. Lipedema: What we don't know. J Plast Reconstr Aesthet Surg. 2023 Sep;84:302-312. doi: 10.1016/j.bjps.2023.05.056. Epub 2023 May 30. PubMed 37390539 ↗
  • WOLD LE, HINES EA Jr, ALLEN EV. Lipedema of the legs; a syndrome characterized by fat legs and edema. Ann Intern Med. 1951 May;34(5):1243-50. doi: 10.7326/0003-4819-34-5-1243. No abstract available. PubMed 14830102 ↗
  • Mortada H, Alhithlool AW, AlBattal NZ, Shetty RK, Al-Mekhlafi GA, Hong JP, Alshomer F. Lipedema: Clinical Features, Diagnosis, and Management. Arch Plast Surg. 2025 May 15;52(3):185-196. doi: 10.1055/a-2530-5875. eCollection 2025 May. PubMed 40386000 ↗

Individual participant data

Plan to share: Undecided

09

Updates

2 registry updates since Sep 25, 2026
Status
Recruiting→Completed
changed Oct 1, 2026
Primary completion
Sep 1, 2026→Aug 31, 2026
moved 2 times, Oct 1, 2026 – Oct 7, 2026
Enrollment
90 (estimated)→100 (actual)
Oct 1, 2026
Primary outcomes
Revised in 2 updates
What changed on Oct 1, 2026
  • AddedClarke's AngleTime frame: At baseline (Day 0).
  • AddedFoot Posture Index-6 (FPI-6) ScoreTime frame: At baseline (Day 0)
  • AddedKnee AlignmentTime frame: At baseline (Day 0)
  • RemovedTendon Cross-Sectional Area (CSA)Time frame: At baseline (Day 0)
What changed on Oct 7, 2026
  • AddedM. Rectus Femoris Muscle ThicknessTime frame: At baseline (Day 0)
  • AddedM. Gastrocnemius Medialis Muscle ThicknessTime frame: At baseline (Day 0)
  • AddedM. Tibialis Posterior Muscle ThicknessTime frame: At Baseline (Day 0)
  • AddedM. Gluteus Medius Muscle ThicknessTime frame: At Baseline (Day 0)
  • AddedGenu ValgumTime frame: At baseline (Day 0)
  • AddedGenu RecurvatumTime frame: At Baseline (Day 0)
  • RemovedLower Extremity Muscle and Tendon ThicknessTime frame: At baseline (Day 0)
  • RemovedKnee AlignmentTime frame: At baseline (Day 0)
across 2 updates, Oct 1, 2026 – Oct 7, 2026
Secondary outcomes
Revised in 2 updates
What changed on Oct 1, 2026
  • ChangedBefore Clarke's AngleNow Tendon Cross-Sectional Area (CSA)Time frame: At baseline (Day 0). → At baseline (Day 0)
  • Removedother outcomeFoot Posture Index-6 (FPI-6) ScoreTime frame: At baseline (Day 0)
What changed on Oct 7, 2026
  • EditedStatic Pedobarographic Weight Distribution Left& RightTime frame: At baseline (Day 0)
  • EditedPatellar Tendon Cross-Sectional Area (CSA)Time frame: At baseline (Day 0)
  • AddedStatic Pedobarographic Weight Distribution Forefoot& HindfootTime frame: At Baseline (Day 0)
  • AddedAchilles Tendon Cross-Sectional Area (CSA)Time frame: At Baseline (Day 0)
  • AddedTibialis Posterior Tendon Cross-Sectional Area (CSA)Time frame: At Baseline (Day 0)
  • DescriptionDynamic Peak Plantar Pressures: how it is measured was reworded
  • Addedother outcomeWaist to Hip RatioTime frame: At Baselin (Day 0)
  • Descriptionother outcome6-Minute Walk Test (6MWT) Distance: how it is measured was reworded
across 2 updates, Oct 1, 2026 – Oct 7, 2026
Show all 2 updates
  1. Oct 7, 2026
    Primary completion Sep 15, 2026→Aug 31, 2026
    Primary outcomes 6 added, 2 removed
    What changed in the outcomes
    • AddedM. Rectus Femoris Muscle ThicknessTime frame: At baseline (Day 0)
    • AddedM. Gastrocnemius Medialis Muscle ThicknessTime frame: At baseline (Day 0)
    • AddedM. Tibialis Posterior Muscle ThicknessTime frame: At Baseline (Day 0)
    • AddedM. Gluteus Medius Muscle ThicknessTime frame: At Baseline (Day 0)
    • AddedGenu ValgumTime frame: At baseline (Day 0)
    • AddedGenu RecurvatumTime frame: At Baseline (Day 0)
    • RemovedLower Extremity Muscle and Tendon ThicknessTime frame: At baseline (Day 0)
    • RemovedKnee AlignmentTime frame: At baseline (Day 0)
    Secondary outcomes 2 edited, 4 added, 2 description edited
    What changed in the outcomes
    • EditedStatic Pedobarographic Weight Distribution Left& RightTime frame: At baseline (Day 0)
    • EditedPatellar Tendon Cross-Sectional Area (CSA)Time frame: At baseline (Day 0)
    • AddedStatic Pedobarographic Weight Distribution Forefoot& HindfootTime frame: At Baseline (Day 0)
    • AddedAchilles Tendon Cross-Sectional Area (CSA)Time frame: At Baseline (Day 0)
    • AddedTibialis Posterior Tendon Cross-Sectional Area (CSA)Time frame: At Baseline (Day 0)
    • DescriptionDynamic Peak Plantar Pressures: how it is measured was reworded
    • Addedother outcomeWaist to Hip RatioTime frame: At Baselin (Day 0)
    • Descriptionother outcome6-Minute Walk Test (6MWT) Distance: how it is measured was reworded
    + 1 other change: verification date
  2. Oct 1, 2026
    Recruiting→Completed
    Primary completion Sep 1, 2026→Sep 15, 2026 (now actual)
    Enrollment 90 (estimated)→100 (actual)
    Primary outcomes 3 added, 1 removed
    What changed in the outcomes
    • AddedClarke's AngleTime frame: At baseline (Day 0).
    • AddedFoot Posture Index-6 (FPI-6) ScoreTime frame: At baseline (Day 0)
    • AddedKnee AlignmentTime frame: At baseline (Day 0)
    • RemovedTendon Cross-Sectional Area (CSA)Time frame: At baseline (Day 0)
    Secondary outcomes 1 edited, 1 removed
    What changed in the outcomes
    • ChangedBefore Clarke's AngleNow Tendon Cross-Sectional Area (CSA)Time frame: At baseline (Day 0). → At baseline (Day 0)
    • Removedother outcomeFoot Posture Index-6 (FPI-6) ScoreTime frame: At baseline (Day 0)
    + 6 other changes: index terms, verification date, description, conditions, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07724483
Lead sponsor
Marmara University
Responsible party
Sponsor
First posted
Jul 24, 2026
Start date
Jul 15, 2026
Primary completion
Aug 31, 2026
Completion
Sep 15, 2026
Last update
Oct 7, 2026

Study contacts

Canan Şanal, Assoc. Prof.
principal investigator · Marmara University Faculty of Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion